Endometriosis Therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
21
NCT07126873
A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes
Phase: Phase 1/2
Role: Lead Sponsor
Start: Aug 11, 2025
Completion: Dec 31, 2029
Loading map...